Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
HomeLaboratoryRoche Diagnostics Middle East Webinar – Role of laboratory diagnostics in COVID-19 severity assessment and management
Webinars and Reports
Webinars and Reports

Roche Diagnostics Middle East Webinar – Role of laboratory diagnostics in COVID-19 severity assessment and management

Webinar-Roche Diagnostics Middle East Webinar – Role of laboratory diagnostics in COVID-19 severity assessment and management

This webinar sheds light on the critical role of biomarkers testing for assessing COVID-19 severity, progression as well as monitoring of therapies.
To watch the webinar, simply sign in or register for free for Omnia Health Insights

Register to view the full article

Register for insights.omniahealth.com and gain access to premium content including whitepapers, videos, and more.

Become a member for free
TAGS: Coronavirus Updates
Related
Reports